XML 34 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Variable Interest Entity
6 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Variable Interest Entity Variable Interest Entity
The Company has substantial governance rights over Profarma Distribuidora de Produtos Farmacêuticos S.A. ("Profarma"), which allow it to direct the activities that significantly impact Profarma’s economic performance. As such, the Company consolidates the operating results of Profarma in its consolidated financial statements. The Company is not obligated to provide future financial support to Profarma.
The following assets and liabilities of Profarma are included in the Company's Consolidated Balance Sheets:
(in thousands)March 31,
2024
September 30,
2023
Cash and cash equivalents$23,152 $33,256 
Accounts receivables, net253,249 253,419 
Inventories252,970 255,801 
Prepaid expenses and other72,782 63,327 
Property and equipment, net49,237 42,759 
Other intangible assets60,243 62,384 
Other long-term assets81,367 77,889 
Total assets$793,000 $788,835 
Accounts payable$294,511 $300,875 
Accrued expenses and other57,604 56,280 
Short-term debt51,010 73,650 
Long-term debt111,598 74,132 
Deferred income taxes20,692 22,701 
Other long-term liabilities57,989 54,691 
Total liabilities$593,404 $582,329 
Profarma's assets can only be used to settle its obligations, and its creditors do not have recourse to the general credit of the Company.